Anti‐infective treatment of severe periodontitis: Hypothetical implementation
Periodontology 2000 · 09.11.2026
DOI: 10.1111/prd.70099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Periodontology 2000, online erschienen am 09.11.2026. Verfasst von Jørgen Slots. Beteiligte Einrichtung: Herman Ostrow School of Dentistry of USC, University of Southern California, Los Angeles, California, USA. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The primary objective of periodontology is to prevent and treat gingivitis and periodontitis to avoid tooth loss and focal infection of periodontal origin. The connection between periodontitis and serious systemic diseases underscores the need to extend periodontal healthcare to individuals across all income levels. A public health initiative needs to employ anti‐infective treatment that effectively targets key periodontal pathogens, delivers long‐term benefits, and is safe and affordable. Materials and Methods Research papers by experienced researchers in clinical periodontics show shortcomings with traditional (mechanical) treatment of moderate‐to‐severe periodontitis (stage 3/4), most likely because of an inability to eradicate periodontal pathogens residing within inflamed gingiva and deep furcation sites. This article proposes augmenting current treatment of severe periodontitis with systemic and local chemotherapeutics against major periodontal pathogens, including active herpesviruses, various anaerobic bacteria, and dental biofilm microorganisms. The therapeutic effectiveness of the individual parts of the suggested therapy is well recognized.
Results
The recommended treatment protocol includes (i) valacyclovir for periodontal herpesviruses on treatment days 1–4, (ii) a pause in pharmacotherapy on days 5–6 to prevent adverse drug interactions, (iii) antibacterial antibiotics like ciprofloxacin‐metronidazole on days 7–11, and (iv) biofilm antiseptics such as sodium hypochlorite for ultrasonic scaling and patient self‐care. The professional anti‐infective therapy may be completed during two office visits on treatment days 1 and 7. Published studies show promising therapeutic outcomes.
Conclusions
The suggested anti‐infective treatment is readily integrated into clinical practice and can be performed as a standalone or an adjunct to traditional periodontal treatment. The treatment is effective, highly safe, and affordable. Dental hygienists can perform a major part of the periodontal therapy. Clinical Relevance This article highlights a decade‐long paradigm shift in periodontology, moving from almost purely physical cleaning to an integrated approach of traditional periodontal methods and targeted pharmaceutical therapies. The hypothetical anti‐infective chemotherapy presented here is low‐cost and effective against periodontal pathogens involved in severe periodontitis, peri‐implantitis, and probably also periodontal‐related systemic diseases. Research is encouraged on the potential of this and future anti‐infective treatments to arrest severe periodontitis and reduce the incidence and severity of systemic diseases related to periodontal disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Herman Ostrow School of Dentistry of USC, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Jørgen Slots
Zitieren
APA
Slots, J. (2026). Anti‐infective treatment of severe periodontitis: Hypothetical implementation. Periodontology 2000. https://doi.org/10.1111/prd.70099
Vancouver
Slots J. Anti‐infective treatment of severe periodontitis: Hypothetical implementation. Periodontology 2000. 2026. doi:10.1111/prd.70099
BibTeX
@article{Slots2026,
author = {Slots, Jørgen},
title = {Anti‐infective treatment of severe periodontitis: Hypothetical implementation},
journal = {Periodontology 2000},
year = {2026},
doi = {10.1111/prd.70099}
}
EUVIMED